NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Thursday, October 4th. Shareholders of record on Wednesday, October 24th will be given a dividend of $0.50 per share on Thursday, November 1st. This represents a $2.00 dividend on an annualized basis and a yield of 2.52%. The ex-dividend date of this dividend is Tuesday, October 23rd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) announced its quarterly earnings results on Tuesday, November, 6th. The pharmacy operator reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.02. The pharmacy operator had revenue of $47.27 billion for the quarter, compared to the consensus estimate of $47.22 billion. CVS Health had a return on equity of 18.69% and a net margin of 1.65%. The company's revenue was up 2.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.50 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY18 earnings guidance on Tuesday, November, 6th. The company provided earnings per share guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.04. CVS Health also updated its FY 2018 guidance to $6.98-7.08 EPS.

17 Wall Street analysts have issued 12 month price targets for CVS Health's stock. Their forecasts range from $76.00 to $100.00. On average, they expect CVS Health's share price to reach $90.9333 in the next year. This suggests a possible upside of 14.6% from the stock's current price. View Analyst Price Targets for CVS Health.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 4 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

News articles about CVS stock have been trending somewhat positive on Sunday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. CVS Health earned a daily sentiment score of 1.6 on InfoTrie's scale. They also gave press coverage about the pharmacy operator a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an effect on the company's share price in the next few days.

CVS Health saw a increase in short interest during the month of October. As of October 31st, there was short interest totalling 58,223,127 shares, an increase of 0.2% from the October 15th total of 58,345,396 shares. Based on an average trading volume of 7,427,896 shares, the days-to-cover ratio is presently 7.8 days. Currently, 5.7% of the shares of the company are short sold. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Rite Aid (RAD), Diplomat Pharmacy (DPLO), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

CVS Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.48%), FMR LLC (2.95%), Dodge & Cox (1.48%), Bank of New York Mellon Corp (1.23%), Franklin Resources Inc. (1.15%) and Veritas Asset Management LLP (1.15%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, The Manufacturers Life Insurance Company , Mitsubishi UFJ Trust & Banking Corp, State Treasurer State of Michigan, Swedbank, PGGM Investments, Bridgewater Associates LP and Mackenzie Financial Corp. Company insiders that have sold CVS Health company stock in the last year include Eva C Boratto, Helena Foulkes, Kevin Hourican, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was acquired by a variety of institutional investors in the last quarter, including Dodge & Cox, Capital International Investors, Diamond Hill Capital Management Inc., BlackRock Inc., Senator Investment Group LP, HealthCor Management L.P., FMR LLC and Point72 Asset Management L.P.. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $79.33.

CVS Health has a market capitalization of $81.42 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]